Shanghai Henlius Biotech, Inc. (HKG:2696)

Hong Kong · Delayed Price · Currency is HKD

69.00

+4.25 (6.56%)

Mar 6, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	5.72B	5.39B	3.21B	1.68B	587.59M
Pharmaceuticals Growth	6.11%	67.82%	91.07%	186.34%	546.20%
Total	5.72B	5.39B	3.21B	1.68B	587.59M
Total Growth	6.11%	67.82%	91.07%	186.34%	546.20%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Mainland China	5.05B	4.81B	2.84B	1.52B	455.47M
Mainland China Growth	4.89%	69.35%	87.42%	232.77%	415.75%
Asia Pacific (Excluding Mainland China)	236.86M	193.99M	178.97M	57.29M	19.91M
Asia Pacific (Excluding Mainland China) Growth	22.10%	8.39%	212.42%	187.75%	660.72%
North America	329.12M	314.79M	145.06M	-	-
North America Growth	4.55%	117.01%	-	-	-
South America	10.62M	19.14M	-	-	-
South America Growth	-44.50%	-	-	-	-
Europe	101.41M	56.37M	50.14M	109.54M	112.20M
Europe Growth	79.91%	12.43%	-54.23%	-2.37%	-
Others	-	-	-	-	12.00K
Oceania	325.00K	-	-	-	-
Total	5.72B	5.39B	3.21B	1.68B	587.59M
Total Growth	6.11%	67.82%	91.07%	186.34%	546.20%

Source: S&P Global Market Intelligence.